Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1996-6-27
pubmed:abstractText
Lytic development of bacteriophage Mu proceeds through three phases of transcription: early, middle, and late. Initiation of middle transcription from Pm requires the phage-encoded activator, Mor. An examination of the sequences surrounding the promoter revealed possible binding sites for Mu proteins A and c, as well as for Escherichia coli integration host factor. Promoter fragments containing 5' and 3' deletions were fused to the lacZ reporter gene and assayed for activity after induction of a Mu prophage or a plasmid-borne mor gene. Sequences upstream of position -62 and downstream of +10 were dispensable for promoter activity. In DNase I footprinting with both crude extract and purified protein, Mor protected Pm sequences from position -56 to -33. Mutations disrupting the dyad symmetry of the terminator of early transcription overlapping the Mor binding site did not reduce promoter activity, suggesting that the symmetry per se is not required for Mor binding or Pm activation. Purified Mu lysogenic repressor (c) also bound to Pm, overlapping the Mor binding site. Production of large amounts of repressor in vivo reduced Mor-dependent promoter activity nearly 10-fold. Promoters with mutations in the repressor binding site showed a reduction in this repressor-mediated inhibition of Pm activity.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-1386645, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-1833382, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-212715, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-2136735, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-2136777, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-2147678, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-2199796, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-2205834, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-2522923, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-2524470, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-2653965, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-2985470, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-3023631, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-3309891, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-3340534, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-3596251, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-3949788, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-4351616, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-4420740, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-6094016, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-6096223, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-6099259, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-622195, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-6227795, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-6242484, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-6282695, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-6310502, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-6450311, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-8001112, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-8205185, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-8293968, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-8366019, http://linkedlifedata.com/resource/pubmed/commentcorrection/8626285-8602357
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-9193
pubmed:author
pubmed:issnType
Print
pubmed:volume
178
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1585-92
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:8626285-Bacteriophage mu, pubmed-meshheading:8626285-Base Sequence, pubmed-meshheading:8626285-DNA Mutational Analysis, pubmed-meshheading:8626285-DNA-Binding Proteins, pubmed-meshheading:8626285-Escherichia coli, pubmed-meshheading:8626285-Gene Expression Regulation, Viral, pubmed-meshheading:8626285-Lysogeny, pubmed-meshheading:8626285-Molecular Sequence Data, pubmed-meshheading:8626285-Promoter Regions, Genetic, pubmed-meshheading:8626285-Protein Binding, pubmed-meshheading:8626285-Recombinant Fusion Proteins, pubmed-meshheading:8626285-Repetitive Sequences, Nucleic Acid, pubmed-meshheading:8626285-Repressor Proteins, pubmed-meshheading:8626285-Sequence Deletion, pubmed-meshheading:8626285-Transcription, Genetic, pubmed-meshheading:8626285-Viral Proteins, pubmed-meshheading:8626285-Viral Regulatory and Accessory Proteins
pubmed:year
1996
pubmed:articleTitle
Regulatory factors acting at the bacteriophage Mu middle promoter.
pubmed:affiliation
Department of Microbiology and Immunology, University of Tennessee-Memphis 38163, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't